Knowledge Management System of Hefei Institute of Physical Science,CAS
Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial. | |
Yuan, Ying; Fu, Xianhua; Ying, Jieer; Yang, Liu; Fang, Weijia; Han, Weidong; Zhang, Suzhan | |
2021-05-20 | |
发表期刊 | JOURNAL OF CLINICAL ONCOLOGY |
ISSN | 0732-183X |
DOI | 10.1200/JCO.2021.39.15_suppl.e15554 |
收录类别 | SCI |
语种 | 英语 |
资助项目 | Jiangsu Hengrui Pharmaceuticals Co., Ltd |
项目资助者 | Jiangsu Hengrui Pharmaceuticals Co., Ltd |
WOS研究方向 | Oncology |
WOS类目 | Oncology |
WOS记录号 | WOS:000708120301219 |
出版者 | LIPPINCOTT WILLIAMS & WILKINS |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.hfcas.ac.cn:8080/handle/334002/126589 |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | 1.Zhejiang Univ, Affiliated Hosp 2, Dept Med Oncol, Sch Med, Hangzhou, Zhejiang, Peoples R China 2.Chinese Acad Sci, Zhejiang Canc Hosp, Inst Canc & Basic Med IBMC, Canc Hosp, Hangzhou, Zhejiang, Peoples R China 3.Peoples Hosp Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China 4.Zhejiang Univ, Affiliated Hosp 1, Dept Med Oncol, Sch Med, Hangzhou, Peoples R China 5.Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Med Oncol, Sch Med, Hangzhou, Zhejiang, Peoples R China 6.Zhejiang Univ, Affiliated Hosp 2, China Natl Minist Educ, Canc Inst Key Lab Canc Prevent & Intervent, Hangzhou, Zhejiang, Peoples R China 7.Zhejiang Univ, Affiliated Hosp 2, Dept Colorectal Surg, Sch Med, Hangzhou, Zhejiang, Peoples R China |
推荐引用方式 GB/T 7714 | Yuan, Ying,Fu, Xianhua,Ying, Jieer,et al. Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39. |
APA | Yuan, Ying.,Fu, Xianhua.,Ying, Jieer.,Yang, Liu.,Fang, Weijia.,...&Zhang, Suzhan.(2021).Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial..JOURNAL OF CLINICAL ONCOLOGY,39. |
MLA | Yuan, Ying,et al."Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial.".JOURNAL OF CLINICAL ONCOLOGY 39(2021). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论